Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: July 2010

Chapter 19 - The epidemiology of preeclampsia with focus on family data

from Section 7: - Risk factors, predictors, and future management

Summary

This chapter deals with the deeper zonal anatomy of the uterus and particularly with the role these areas have in controlling uterine movements. The morphology of the junctional zone (JZ) suggests a distinct compartment of myometrium, tightly packed with muscle cells with an increased vascularity, designed as it were for a specific purpose. The JZ is responsive to changes in sex steroid levels, and undergoes a cycle of change which parallels the changes in endometrial thickness. Rapidly developing technology allows better images and the introduction of ever more complex classification of JZ contractions (JZC). The frequent use of ultrasound during assisted conception cycles provides most of the information we have about JZC, with most data coming from the study of long protocol stimulation in vitro fertilization (IVF) cycles. Excessive JZC have been shown to reduce implantation rates in both spontaneous and stimulated cycles.

Related content

Powered by UNSILO

References

1. BassoO, RasmussenS, WeinbergC Ret al. Trends in fetal and infant survival following preeclampsia. Jama 2006; 296(11): 1357–62.
2. BartonJ R, SibaiB M. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008; 112(2 Pt 1): 359–72.
3. SkjaervenR, WilcoxA J, LieR T, IrgensL M. Selective fertility and the distortion of perinatal mortality. Am J Epidemiol 1988; 128(6): 1352–63.
4. SkjaervenR, MelveK K. Selective fertility: the examples of perinatal death and preeclampsia. Norsk Epidemiologi 2007; 17(2): 175–80.
5. NeedJ A. Pre-eclampsia in pregnancies by different fathers: immunological studies. BMJ 1975; 1(5957): 548–9.
6. RobillardP Y, DekkerG A, HulseyT C. Revisiting the epidemiological standard of preeclampsia: primigravidity or primipaternity? Eur J Obstet Gynecol Reprod Biol 1999; 84(1): 37–41.
7. RobillardP Y, HulseyT C, AlexanderG Ret al. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J Reprod Immunol 1993; 24(1): 1–12.
8. TrupinL S, SimonL P, EskenaziB. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology 1996; 7(3): 240–4.
9. DekkerG A, SibaiB M. Etiology and pathogenesis of preeclampsia: current concepts [see comments]. Am J Obstet Gynecol 1998; 179(5): 1359–75.
10. DekkerG A, RobillardP Y, HulseyT C. Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. Obstet Gynecol Surv 1998; 53(6): 377–82.
11. BassoO, ChristensenK, OlsenJ. Higher risk of pre-eclampsia after change of partner: an effect of longer interpregnancy intervals? Epidemiology 2001; 12(6): 624–9.
12. SkjaervenR, WilcoxA J, LieR T. The interval between pregnancies and the risk of preeclampsia. N Engl J Med 2002; 346(1): 33–8.
13. TrogstadL I, EskildA, MagnusP, SamuelsenS O, NesheimB I. Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 547 238 women with and without previous pre-eclampsia. Int J Epidemiol 2001; 30(6): 1317–22.
14. DeenM E, RuurdaL G, WangJ, DekkerG A. Risk factors for preeclampsia in multiparous women: primipaternity versus the birth interval hypothesis. J Matern Fetal Neonatal Med 2006; 19(2): 79–84.
15. DekkerG, RobillardP Y. The birth interval hypothesis: does it really indicate the end of the primipaternity hypothesis? J Reprod Immunol 2003; 59(2): 245–51.
16. HjartardottirS, LeifssonB G, GeirssonR T, SteinthorsdottirV. Paternity change and the recurrence risk in familial hypertensive disorder in pregnancy. Hypertens Pregnancy 2004; 23(2): 219–25.
17. ZhangJ, PatelG. Partner change and perinatal outcomes: a systematic review. Paediatr Perinat Epidemiol 2007; 21(Suppl 1): 46–57.
18. CnattingiusS, MillsJ L, YuenJ, ErikssonO, SalonenH. The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am J Obstet Gynecol 1997; 177(1): 156–61.
19. VattenL J, SkjaervenR. Effects on pregnancy outcome of changing partner between first two births: prospective population study. BMJ 2003; 327(7424): 1138.
20. DekkerG, RobillardP Y. Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update. J Reprod Immunol 2007; 76(1–2): 8–16.
21. LiD K, WiS. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am J Epidemiol 2000; 151(1): 57–62.
22. LieR T, RasmussenS, BrunborgHet al. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998; 316(7141): 1343–7.
23. GuelinckxI, DevliegerR, BeckersK, VansantG. Maternal obesity: pregnancy complications, gestational weight gain and nutrition. Obes Rev 2008; 9(2): 140–50.
24. CatalanoP M. Increasing maternal obesity and weight gain during pregnancy: the obstetric problems of plentitude. Obstet Gynecol 2007; 110(4): 743–4.
25. CatalanoP M. Management of obesity in pregnancy. Obstet Gynecol 2007; 109(2 Pt 1): 419–33.
26. VillamorE, CnattingiusS. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 2006; 368(9542): 1164–70.
27. EsplinM S, FausettM B, FraserAet al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001; 344(12): 867–72.
28. Salonen RosH, LichtensteinP, LipworthL, CnattingiusS. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet 2000; 91(4): 256–60.
29. CnattingiusS, ReillyM, PawitanY, LichtensteinP. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A 2004; 130A(4): 365–71.
30. SkjaervenR, VattenL J, WilcoxA Jet al. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 2005; 331(7521): 877.
31. EskenaziB, FensterL, SidneyS, ElkinE P. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol 1993; 169(5): 1112–8.
32. XiongX, MayesD, DemianczukNet al. Impact of pregnancy-induced hypertension on fetal growth. Am J Obstet Gynecol 1999; 180(1 Pt 1): 207–13.
33. VattenL J, SkjaervenR. Is pre-eclampsia more than one disease? BJOG 2004; 111(4): 298–302.
34. SkjaervenR, GjessingH K, BakketeigL S. Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand 2000; 79(6): 440–9.
35. XiongX, DemianczukN N, BuekensP, SaundersL D. Association of preeclampsia with high birth weight for age. Am J Obstet Gynecol 2000; 183(1): 148–55.
36. RasmussenS, IrgensL M, AlbrechtsenS, DalakerK. Predicting preeclampsia in the second pregnancy from low birth weight in the first pregnancy. Obstet Gynecol 2000; 96(5 Pt 1): 696–700.
37. ZhangJ, TroendleJ F, LevineR J. Risks of hypertensive disorders in the second pregnancy. Paediatr Perinat Epidemiol 2001; 15(3): 226–31.
38. ZetterstromK, LindebergS, HaglundB, MagnusonA, HansonU. Being born small for gestational age increases the risk of severe pre-eclampsia. BJOG 2007; 114(3): 319–24.
39. RasmussenS, IrgensL M. Pregnancy-induced hypertension in women who were born small. Hypertension 2007; 49(4): 806–12.
40. NessR B, RobertsJ M. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996; 175(5): 1365–70.
41. RobertsJ M, RedmanC W. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341(8858): 1447–51.
42. RobertsJ M, CatovJ M. Preeclampsia more than 1 disease: or is it? Hypertension 2008; 51(4): 989–90.
43. HaigD. Genetic conflicts in human pregnancy. Q Rev Biol 1993; 68(4): 495–532.
44. IrgensH U, ReisaeterL, IrgensL M, LieR T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323(7323): 1213–7.
45. FunaiE F, FriedlanderY, PaltielOet al. Long-term mortality after preeclampsia. Epidemiology 2005; 16(2): 206–15.
46. VikseB E, IrgensL M, LeivestadT, SkjaervenR, IversenB M. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008; 359(8): 800–9.
47. TrogstadL, SkrondalA, StoltenbergCet al. Recurrence risk of preeclampsia in twin and singleton pregnancies. Am J Med Genet A 2004; 126(1): 41–5.
48. SmithG C, ShahI, WhiteI R, PellJ P, DobbieR. Previous preeclampsia, preterm delivery, and delivery of a small for gestational age infant and the risk of unexplained stillbirth in the second pregnancy: a retrospective cohort study, Scotland, 1992–2001. Am J Epidemiol 2007; 165(2): 194–202.